Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.
Current Team (9)Update
COO & Board Director
Director, Open Innovation
Co - Founder, Office Of The CSO & Chairman, SAB
Co - Founder & CEO & Board Director
Director, Antibody Discovery & Optimization
Associate Director, Antibody Discovery and Bispecific Engineering
VP, Head, Business Development
Funding Rounds (9) - $39.7MUpdate
Board Members and Advisors (5)Update
Google Ventures is the venture capital investment arm of Google Inc.
Venture capital Firm
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
Borealis Ventures partners closely with exceptional entrepreneurs from the earliest stages to...
16 Cavendish Court
Lebanon, NH 03766